AstraZeneca says covid-19 booster shot was effective against omicron in study

The pharmaceutical company said antibody levels against Omicron following a third dose of its vaccine were broadly similar to antibody levels against the Delta variant achieved after two doses.

The study, conducted by the University of Oxford, supports the use of the vaccine as a third-dose booster against the Omicron variant, AstraZeneca said.

This story has been published from a wire agency feed without modifications to the text